Zosuquidar (LY335979): P-gp Inhibitor for Multidrug Resis...

2026-01-19

Zosuquidar (LY335979) 3HCl stands out as a precise, selective P-glycoprotein modulator for overcoming cancer multidrug resistance (MDR) in both bench and translational research. This guide details experimental workflows, troubleshooting solutions, and advanced use-cases, empowering researchers to maximize chemosensitization and reproducibility using APExBIO’s trusted reagent.